• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

F11C抗原:一种能够区分大鼠结肠腺癌的两种退行性和进行性变体的膜标记物。

F11C antigen: a membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma.

作者信息

Caignard A, Genne P, Olsson N O, Oriol R, Martin F

机构信息

INSERM U.252, Faculty of Medicine, Dijon, France.

出版信息

Int J Cancer. 1990 Oct 15;46(4):633-9. doi: 10.1002/ijc.2910460414.

DOI:10.1002/ijc.2910460414
PMID:1698729
Abstract

Cell variants that differ in their tumorigenicity and immunogenicity have been isolated from a BDIX rat colon adenocarcinoma cell line, DHD/K12. One variant, PRO, and the clones derived from it, are poorly immunogenic and induce progressive and metastatic tumors; the other one, REG, and its clones, are highly immunogenic and induce regressive tumors. When looking for a membrane marker distinguishing between PRO and REG lines, we obtained monoclonal hybridomas by immunizing BALB/c mice with PROb or REGb cell clones. Hybridoma F11C, producing an IgM monoclonal antibody (MAb) was able to distinguish between the cell variants on membrane immunofluorescence. All REGb cells strongly express F11C membrane antigen. On PROb cells, F11C antigen expression is weak, as demonstrated by cytofluorimetric analysis, and limited to a fraction of the cell population. The F11C membrane antigen is highly specific for the DHD/K12 cell line and the variants derived from it, but is not expressed on cells dissociated from the DHD transplanted tumor, from which DHD/K12 was established, suggesting that F11C antigen emerged during cell culture. Fluorescence absorption on synthetic oligosaccharides demonstrated that F11C antibody cross-reacts with A type 3, A type 4 and A type 5 chain blood group tetrasaccharides.

摘要

已从BDIX大鼠结肠腺癌细胞系DHD/K12中分离出具有不同致瘤性和免疫原性的细胞变体。一种变体PRO及其衍生克隆免疫原性较差,可诱导进行性和转移性肿瘤;另一种变体REG及其克隆具有高度免疫原性,可诱导肿瘤消退。在寻找区分PRO和REG细胞系的膜标志物时,我们用PROb或REGb细胞克隆免疫BALB/c小鼠,获得了单克隆杂交瘤。产生IgM单克隆抗体(MAb)的杂交瘤F11C能够通过膜免疫荧光区分细胞变体。所有REGb细胞均强烈表达F11C膜抗原。通过细胞荧光分析表明,PROb细胞上F11C抗原表达较弱,且仅限于一部分细胞群体。F11C膜抗原对DHD/K12细胞系及其衍生变体具有高度特异性,但在从建立DHD/K12的DHD移植瘤中解离出的细胞上不表达,这表明F11C抗原是在细胞培养过程中出现的。对合成寡糖的荧光吸收表明,F11C抗体与A3型、A4型和A5型血型四糖发生交叉反应。

相似文献

1
F11C antigen: a membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma.F11C抗原:一种能够区分大鼠结肠腺癌的两种退行性和进行性变体的膜标记物。
Int J Cancer. 1990 Oct 15;46(4):633-9. doi: 10.1002/ijc.2910460414.
2
Specificity of the immune response leading to protection or enhancement by regressive and progressive variants of a rat colon carcinoma.大鼠结肠癌的退行性和进行性变体导致保护或增强的免疫反应的特异性。
Int J Cancer. 1988 Dec 15;42(6):883-6. doi: 10.1002/ijc.2910420616.
3
Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cells.两种致瘤性不同的大鼠结肠腺癌变体对自然细胞介导的细胞毒性的差异敏感性:效应细胞鉴定为自然杀伤细胞。
Cancer Immunol Immunother. 1988;26(3):263-8. doi: 10.1007/BF00199939.
4
In vivo and in vitro reactivity of rat spleen cells against regressor and progressor colon-cancer cell variants.大鼠脾细胞对消退型和进展型结肠癌细胞变体的体内和体外反应性。
Int J Cancer. 1993 Feb 20;53(4):651-6. doi: 10.1002/ijc.2910530421.
5
In vitro proliferative responses of spleen lymphocytes from rats bearing progressive or regressive tumors induced by cell variants of a syngeneic colon carcinoma.同基因结肠癌细胞变体诱导的进展性或消退性肿瘤大鼠脾脏淋巴细胞的体外增殖反应。
Int J Cancer. 1989 Feb 15;43(2):334-9. doi: 10.1002/ijc.2910430228.
6
Cytotoxic activity of lymphocytes infiltrating progressive and regressive tumor variants from a rat colonic cancer.浸润大鼠结肠癌进展期和消退期肿瘤变体的淋巴细胞的细胞毒性活性
Immunobiology. 1991 Mar;182(2):188-96. doi: 10.1016/S0171-2985(11)80203-2.
7
Histological reactivity of a monoclonal antibody against rat colon cancer cells on human and rat normal gut and colonic tumours.一种抗大鼠结肠癌细胞的单克隆抗体对人和大鼠正常肠道及结肠肿瘤的组织学反应性。
Virchows Arch A Pathol Anat Histopathol. 1992;420(3):233-42. doi: 10.1007/BF01600276.
8
In vitro natural killer activity against progressive and regressive variants of a rat colon adenocarcinoma. Effect of treatments with anti-asialo GM1 plus complement.体外针对大鼠结肠腺癌进展期和消退期变体的自然杀伤活性。抗唾液酸GM1加补体处理的效果。
Immunobiology. 1987 Sep;175(3):202-13. doi: 10.1016/S0171-2985(87)80029-3.
9
Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.大鼠结肠癌中肿瘤免疫原性与诱导型而非组成型热休克蛋白70表达的共分离。
J Immunol. 1995 Jul 15;155(2):740-7.
10
In vivo localization of human colon adenocarcinoma by monoclonal antibody binding to a highly expressed cell surface antigen.通过单克隆抗体与高表达细胞表面抗原结合对人结肠腺癌进行体内定位。
Cancer Res. 1988 Nov 15;48(22):6573-9.

引用本文的文献

1
Subcutaneous or intrahepatic injection of suicide gene modified tumour cells induces a systemic antitumour response in a metastatic model of colon carcinoma in rats.皮下或肝内注射自杀基因修饰的肿瘤细胞可在大鼠结肠癌转移模型中诱导全身性抗肿瘤反应。
Gut. 2002 Mar;50(3):387-91. doi: 10.1136/gut.50.3.387.
2
Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.人及实验性结直肠癌中纤连蛋白ED - A +和ED - B +亚型的表达。癌细胞和肿瘤相关肌成纤维细胞的作用。
Am J Pathol. 1996 Feb;148(2):579-92.
3
Histological reactivity of a monoclonal antibody against rat colon cancer cells on human and rat normal gut and colonic tumours.
一种抗大鼠结肠癌细胞的单克隆抗体对人和大鼠正常肠道及结肠肿瘤的组织学反应性。
Virchows Arch A Pathol Anat Histopathol. 1992;420(3):233-42. doi: 10.1007/BF01600276.